| Apoptosis-modulating agents in combination with radiotherapy—current status and outlook C Belka, V Jendrossek, M Pruschy, S Vink, M Verheij, W Budach International Journal of Radiation Oncology* Biology* Physics 58 (2), 542-554, 2004 | 178 | 2004 |
| Stoffenmanager nano version 1.0: a web-based tool for risk prioritization of airborne manufactured nano objects B Van Duuren-Stuurman, SR Vink, KJM Verbist, HGA Heussen, ... Annals of occupational hygiene 56 (5), 525-541, 2012 | 172 | 2012 |
| A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells AH van der Luit, SR Vink, JB Klarenbeek, D Perrissoud, E Solary, ... Molecular cancer therapeutics 6 (8), 2337-2345, 2007 | 163 | 2007 |
| Rationale and clinical application of alkylphospholipid analogues in combination with radiotherapy SR Vink, WJ van Blitterswijk, JHM Schellens, M Verheij Cancer treatment reviews 33 (2), 191-202, 2007 | 104 | 2007 |
| Phase I and pharmacokinetic study of combined treatment with perifosine and radiation in patients with advanced solid tumours SR Vink, JHM Schellens, JH Beijnen, H Sindermann, J Engel, ... Radiotherapy and Oncology 80 (2), 207-213, 2006 | 94 | 2006 |
| Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid SR Vink, JHM Schellens, WJ van Blitterswijk, M Verheij Investigational new drugs 23, 279-286, 2005 | 91 | 2005 |
| Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts SR Vink, S Lagerwerf, E Mesman, JHM Schellens, AC Begg, ... Clinical cancer research 12 (5), 1615-1622, 2006 | 65 | 2006 |
| Enriching lipid nanovesicles with short‐chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors M van Lummel, WJ van Blitterswijk, SR Vink, RJ Veldman, ... The FASEB Journal 25 (1), 280-289, 2011 | 64 | 2011 |
| Use of read-across and tiered exposure assessment in risk assessment under REACH–a case study on a phase-in substance SR Vink, J Mikkers, T Bouwman, H Marquart, ED Kroese Regulatory Toxicology and Pharmacology 58 (1), 64-71, 2010 | 58 | 2010 |
| TRAIL enhances efficacy of radiotherapy in a p53 mutant, Bcl-2 overexpressing lymphoid malignancy EHJ Wissink, I Verbrugge, SR Vink, MB Schader, U Schaefer, H Walczak, ... Radiotherapy and oncology 80 (2), 214-222, 2006 | 57 | 2006 |
| Lipid rafts and metabolic energy differentially determine uptake of anti-cancer alkylphospholipids in lymphoma versus carcinoma cells SR Vink, AH van der Luit, JB Klarenbeek, M Verheij, WJ van Blitterswijk Biochemical pharmacology 74 (10), 1456-1465, 2007 | 51 | 2007 |
| Coformulated N-octanoyl-glucosylceramide improves cellular delivery and cytotoxicity of liposomal doxorubicin RJ Veldman, GA Koning, A van Hell, S Zerp, SR Vink, G Storm, M Verheij, ... Journal of Pharmacology and Experimental Therapeutics 315 (2), 704-710, 2005 | 38 | 2005 |
| Stoffenmanager Nano: Description of the conceptual control banding model B Van Duuren-Stuurman, SR Vink, DH Brouwer, DED Kroese, ... TNO Report, 2011 | 31 | 2011 |
| Alkylphospholipids inhibit capillary-like endothelial tube formation in vitro: antiangiogenic properties of a new class of antitumor agents SF Zerp, SR Vink, GA Ruiter, P Koolwijk, E Peters, AH van der Luit, ... Anti-cancer drugs 19 (1), 65-75, 2008 | 30 | 2008 |
| Improved anti-tumor efficacy of glucosylceramide-enriched liposomal doxorubicin M van Lummel, G Koning, RJ Veldman, S Vink, S Zerp, W van Blitterswijk, ... Cancer Research 67 (9_Supplement), 2263-2263, 2007 | 1 | 2007 |
| The oral alkyl-phosphocholine perifosine potentiates the antitumor effect of radiation in vitro and in vivo SR Vink, JHM Schellens, J Engel, H Sindermann, H Bartelink, M Verheij RADIOTHERAPY AND ONCOLOGY 73, S426-S427, 2004 | 1 | 2004 |
| hapter 3.2 hapter 3.2 SR Vink, S Lagerwerf, E Mesman, JHM Schellens, AC Begg, ... Alkylphospholipids combined with radiotherapy; translational studies 12, 119, 2007 | | 2007 |
| Trail enhances efficacy of radiotherapy in a p53 mutant, Bcl-2 overexpressing lymphoid malignancy M Verheij, E Wissink, I Verbrugge, S Vink, M Schader, U Schaefer, ... RADIOTHERAPY AND ONCOLOGY 81, S31-S32, 2006 | | 2006 |
| Phase I study of combined treatment with the oral alkyl-phospholipid (APL) perifosine and radiation in patients with advanced solid tumors M Verheij, S Vink, JHM Schellens, JH Beijnen, H Sindermann, J Engel, ... RADIOTHERAPY AND ONCOLOGY 73, S108-S108, 2004 | | 2004 |
| First results of a clinical phase I study of concurrent daily oral administration of perifosine and radiotherapy in patients with advanced solid tumors S Vink, JHM Schellens, JH Beijnen, J Engei, H Sindermann, H Bartelink, ... | | |
